Search research articles
Contact Us
Filters
Showing results (61-70 of 107) with videos related to
Page
of 11
Sort By:
Biorxiv : the Preprint Server for Biology
|
February 12, 2026
HistoSweep enables cellular-resolution tissue quality control for gigapixel images in digital pathology and spatial omics
Amelia Schroeder, Xiaokang Yu, Wei Li, et al.
JCI Insight
|
May 10, 2022
MEF2C opposes Notch in lymphoid lineage decision and drives leukemia in the thymus
Kirsten Canté-Barrett, Mariska T Meijer, Valentina Cordo', et al.
Research Square
|
February 7, 2023
scMINER: a mutual information-based framework for identifying hidden drivers from single-cell omics data
Liang Ding, Hao Shi, Chenxi Qian, et al.
Nature
|
December 13, 2019
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy
Jun Wei, Lingyun Long, Wenting Zheng, et al.
Biorxiv : the Preprint Server for Biology
|
February 7, 2023
scMINER: a mutual information-based framework for identifying hidden drivers from single-cell omics data
Liang Ding, Hao Shi, Chenxi Qian, et al.
Frontiers in Oncology
|
July 3, 2020
Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer
Douglas K Marks, Robyn D Gartrell, Margueritta El Asmar, et al.
Nature Communications
|
May 4, 2023
NetBID2 provides comprehensive hidden driver analysis
Xinran Dong, Liang Ding, Andrew Thrasher, et al.
Breast Cancer Research : BCR
|
April 21, 2017
Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Preeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, et al.
Breast Cancer Research : BCR
|
December 9, 2015
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Preeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, et al.
Genes & Development
|
August 1, 2015
Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers
Ruth Rodriguez-Barrueco, Jiyang Yu, Laura P Saucedo-Cuevas, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 107) with videos related to
Sort By:
Page
of 11
Biorxiv : the Preprint Server for Biology
|
February 12, 2026
HistoSweep enables cellular-resolution tissue quality control for gigapixel images in digital pathology and spatial omics
Amelia Schroeder, Xiaokang Yu, Wei Li, et al.
JCI Insight
|
May 10, 2022
MEF2C opposes Notch in lymphoid lineage decision and drives leukemia in the thymus
Kirsten Canté-Barrett, Mariska T Meijer, Valentina Cordo', et al.
Research Square
|
February 7, 2023
scMINER: a mutual information-based framework for identifying hidden drivers from single-cell omics data
Liang Ding, Hao Shi, Chenxi Qian, et al.
Nature
|
December 13, 2019
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy
Jun Wei, Lingyun Long, Wenting Zheng, et al.
Biorxiv : the Preprint Server for Biology
|
February 7, 2023
scMINER: a mutual information-based framework for identifying hidden drivers from single-cell omics data
Liang Ding, Hao Shi, Chenxi Qian, et al.
Frontiers in Oncology
|
July 3, 2020
Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer
Douglas K Marks, Robyn D Gartrell, Margueritta El Asmar, et al.
Nature Communications
|
May 4, 2023
NetBID2 provides comprehensive hidden driver analysis
Xinran Dong, Liang Ding, Andrew Thrasher, et al.
Breast Cancer Research : BCR
|
April 21, 2017
Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Preeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, et al.
Breast Cancer Research : BCR
|
December 9, 2015
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Preeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, et al.
Genes & Development
|
August 1, 2015
Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers
Ruth Rodriguez-Barrueco, Jiyang Yu, Laura P Saucedo-Cuevas, et al.
Page
of 11